Case Study: Global Pharma/Biotech uncovers $6M in contract noncompliance with apexanalytix

Global Pharma/Biotech Uncovering the hidden costs of contract noncompliance

Global Pharma/Biotech, a leading global biopharmaceutical company operating in more than 100 countries, wanted to verify that strategic suppliers were following contract terms. However, its supplier relationships were largely trust-based, transparency into adherence was limited, and internal resources were not available to perform the needed compliance checks.

The company engaged apexanalytix to conduct technology-enabled contract compliance and recovery audits across three suppliers representing nearly $200 million in annual spend. apexanalytix identified unauthorized and duplicate charges, overbilling, missed discounts, and unpaid volume rebates, delivering more than $6 million in recoveries and an estimated 3%–5% return on audited spend, along with recommendations to tighten contract language and improve ongoing monitoring.